Skip to main content
Global Bioenergies logo

Global Bioenergies — Investor Relations & Filings

Ticker · ALGBE ISIN · FR0011052257 LEI · 969500H46XRAMTMVB676 PA Manufacturing
Open in API
Filings indexed 443 across all filing types
Latest filing 2022-11-16 Regulatory Filings
Country FR France
Listing PA ALGBE

About Global Bioenergies

https://www.global-bioenergies.com/?lan…

Global Bioenergies develops and commercializes a process to convert renewable resources, such as plant-based sugars and agricultural waste, into isobutene. The company's proprietary technology utilizes fermentation and synthetic biology to produce this key hydrocarbon, which serves as a platform molecule for various applications. The bio-isobutene can be converted into ingredients for the cosmetics industry, specialty chemicals, and renewable fuels. A primary strategic focus is the production of Sustainable Aviation Fuel (SAF) to support the decarbonization of the aviation sector. The process provides a bio-based alternative to petroleum-derived hydrocarbons, aiming to reduce CO2 emissions and dependence on fossil fuels.

Recent filings

Filing Released Lang Actions
Global Bioenergies delivers a batch of sustainable aviation fuel for tests commissioned by French Ministry of the Armed Forces
Regulatory Filings Classification · 95% confidence The document is a press release dated November 16, 2022, announcing that Global Bioenergies delivered a batch of sustainable aviation fuel for tests commissioned by the French Ministry of the Armed Forces (DGA). It details a specific operational/project update related to fuel testing and military strategy. This type of announcement, which is not a formal financial filing (like 10-K, ER, or IR), nor a management change (MANG) or dividend notice (DIV), fits best under the general category for regulatory or significant operational announcements that don't have a more specific code. Since it is a press release detailing a specific operational milestone/partnership, and it is not a formal financial report, it is classified as a Regulatory Filing (RNS) as the most appropriate general announcement category, although it could also be argued as a general Investor Relations update. Given the options, RNS serves as the best fit for a non-standard, non-financial regulatory/operational announcement.
2022-11-16 English
Global Bioenergies livre un lot de carburant d’aviation durable pour des tests commandés par le Ministère des Armées
Regulatory Filings Classification · 95% confidence The document is titled "COMMUNIQUE DE PRESSE" (Press Release) and announces a specific operational event: the delivery of sustainable aviation fuel for testing commissioned by the Ministry of the Armed Forces (Ministère des Armées) under the GENOPTAIRE project. This is a factual announcement about a business development, not a comprehensive financial report (like 10-K or IR), a management change (MANG), or a formal regulatory filing detailing voting results or insider trades. Since it is a press release announcing a specific, non-financial corporate event, it fits best under the general category for regulatory announcements or press releases that don't fit other specific categories. Given the options, 'Regulatory Filings' (RNS) serves as the best general category for official, non-standardized corporate announcements like this press release, although 'LTR' (Legal Proceedings Report) or 'TAR' (M&A) are clearly incorrect. It is not an Earnings Release (ER) as it contains no financial results. Therefore, RNS is the most appropriate fallback.
2022-11-16 French
Global Bioenergies : Collaboration avec Shell pour le développement de carburants routiers bas carbone
Regulatory Filings Classification · 95% confidence The document is a press release dated November 14, 2022, announcing a collaboration between Global Bioenergies and Shell to develop low-carbon road fuels. It details the scope of the agreement (evaluating high-octane gasoline components from bio-based feedstocks) and includes quotes from management. This type of announcement, focusing on strategic partnerships, R&D progress, or significant operational updates outside of mandatory financial reporting periods (like 10-K or IR), typically falls under general regulatory announcements or news releases. Since it is not a formal financial report (like ER, IR, 10-K), a management discussion (MDA), or a specific transaction (CAP, TAR), the most appropriate general category is Regulatory Filings (RNS), which serves as a broad category for significant corporate news releases that don't fit elsewhere. The document length is short (3243 chars), but it is the primary content, not an announcement *of* another report, so RPA is less suitable than RNS for this type of strategic news.
2022-11-14 French
Global Bioenergies agrees collaboration with Shell in the development of low carbon road fuels
Regulatory Filings Classification · 95% confidence The document is a press release dated November 14, 2022, announcing a collaboration agreement between Global Bioenergies and Shell regarding the development of low-carbon road fuels. It details the scope of the research study and includes quotes from executives. This type of announcement, which is not a formal regulatory filing like a 10-K, an earnings release (ER), or a specific financial report (like IR or AR), but rather a general corporate update about a strategic partnership, fits best under the general 'Regulatory Filings' category (RNS) as a miscellaneous corporate announcement, or potentially as a general 'LTR' if it were a legal agreement update, but RNS is the most appropriate fallback for general news releases that don't fit the other specific categories like DIV, CAP, or MANG. Given the options, RNS serves as the best catch-all for significant, non-financial-reporting news.
2022-11-14 English
Global Bioenergies renews equity line with Kepler Cheuvreux to support industrial deployment
Share Issue/Capital Change Classification · 99% confidence The document is a press release dated November 11, 2022, announcing the renewal of an equity line financing agreement with Kepler Cheuvreux to support industrial deployment and prefinancing production. This announcement details a specific financing activity, including the maximum amount (€11 million), the mechanism (share subscription based on VWAP), and the intended use of funds (prefinancing production and engineering studies for a new plant). This clearly falls under the category of updates on company fundraising or capital structure changes. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2022-11-11 English
Global Bioenergies renouvelle sa ligne de financement en fonds propres avec Kepler Cheuvreux pour accompagner son déploiement industriel
Capital/Financing Update Classification · 99% confidence The document announces the renewal of a proprietary equity financing line ('ligne de financement en fonds propres') with Kepler Cheuvreux, aiming to raise up to 11 million euros through the issuance of new shares over 24 months. This activity directly relates to the company's fundraising, financing structure, and capital management. This aligns perfectly with the definition of 'Capital/Financing Update' (CAP). It is not an earnings release (ER), an interim report (IR), or a formal annual report (10-K). It is a specific announcement about securing capital, making CAP the most appropriate classification.
2022-11-11 French

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.